Table 2.
Multivariate Analysis of Cachexia Incidence at Cancer Diagnosis
| Category | Parameter | OR (95% CI) | p value |
|---|---|---|---|
| Patient information | Age at diagnosis (y) | 1.005 (0.989–1.021) | 0.5618 |
| Female sex | 0.719 (0.520–0.994) | 0.0457 | |
| Race | |||
| Non-Hispanic White | - | 0.1575 | |
| Black | 1.558 (1.051–2.309) | 0.0272 | |
| Asian | 0.982 (0.470–2.050) | 0.9606 | |
| Hispanic | 1.285 (0.722–2.288) | 0.3937 | |
| Private insurance | 0.692 (0.496–0.964) | 0.0298 | |
| Risk factors | Charlson comorbidity score | 1.005 (0.954–1.058) | 0.8620 |
| Pretreatment BMI | 0.981 (0.954–1.008) | 0.1641 | |
| Alcohol history | 1.045 (0.751–1.453) | 0.7948 | |
| Tobacco history | 1.606 (1.027–2.510) | 0.0377 | |
| Tumor characteristics | Cell morphology | ||
| Adenocarcinoma | - | 0.4141 | |
| Squamous cell | 1.326 (0.867–2.027) | 0.1929 | |
| Large cell | 1.117 (0.373–3.345) | 0.8427 | |
| Mixed or NOS | 1.414 (0.834–2.399) | 0.1983 |
BMI, body mass index; CI, confidence interval; NOS, not otherwise specified.